ABCL - Abcellera Biologics  - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

ABCL is currently covered by 3 analysts with an average price target of $7. This is a potential upside of $7.1 (2.94%) from yesterday's end of day stock price of $6.8.

Abcellera Biologics 's activity chart (see below) currently has 26 price targets and 23 ratings on display. The stock rating distribution of ABCL is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 34.15% with an average time for these price targets to be met of 117.05 days.

Highest price target for ABCL is $10, Lowest price target is $4, average price target is $7.

Most recent stock forecast was given by from JEFFERIES on 07-Nov-2025.

Best performing analysts who are covering ABCL - Abcellera Biologics :

Scott Schoenhaus Faisal Khurshid Srikripa Devarakonda Stephen Willey

Currently out of the existing stock ratings of ABCL, 3 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 07-Jul-2025

$4

$-3.38 (-45.80%)

$5

8 months 4 days ago
(07-Nov-2025)

2/2 (100%)

$0.09 (2.30%)

9

Hold Since 05-Nov-2024

10 months 28 days ago
(13-Aug-2025)

0/3 (0%)

$6.55 (120.18%)

Buy Since 05-Jan-2021

$7

$-0.38 (-5.15%)

$10

11 months 3 days ago
(08-Aug-2025)

1/7 (14.29%)

$2.75 (64.71%)

322

Buy Since 05-Dec-2023

$10

$2.62 (35.50%)

$5

11 months 27 days ago
(14-Jul-2025)

7/9 (77.78%)

$5.76 (135.85%)

458

Buy Since 16-May-2025

$10

$2.62 (35.50%)

1 years 1 months 25 days ago
(16-May-2025)

0/1 (0%)

$7.97 (392.61%)

Show more analysts

Please expand the browser size to see the chart

What is ABCL (Abcellera Biologics ) average time for price targets to be met?

On average it took 117.05 days on average for the stock forecasts to be realized with a an average price target met ratio 34.15

Which analyst has the current highest performing score on ABCL (Abcellera Biologics ) with a proven track record?

Which analyst has the most public recommendations on ABCL (Abcellera Biologics )?

has 0 price targets and 0 ratings on ABCL

Which analyst is the currently most bullish on ABCL (Abcellera Biologics )?

Gal Munda with highest potential upside - $49.73

Which analyst is the currently most reserved on ABCL (Abcellera Biologics )?

Faisal Khurshid with lowest potential downside - -$3.38

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?